Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency [View all]

Starnes..com

https://www.statnews.com/2026/03/06/fda-vinay-prasad-controversial-cber-director-leaving/

“
WASHINGTON — Vinay Prasad, a top official at the Food and Drug Administration who has been at the center of recurring public controversies, is exiting the agency for a second time.

Prasad will leave the FDA at the end of April, and his replacement has not yet been identified, FDA Commissioner Marty Makary told The Wall Street Journal.”

In a social media post, Makary thanked Prasad for his work at the agency, highlighting Prasad’s role in reducing the number of clinical trials required to approve a drug, limiting Covid vaccine approvals to those over 65 or with risk factors, developing a new pathway for individualized medicines, and helping launch a new speedy drug review program. Makary said the same in a note to staff, viewed by STAT.”